Posted in | News

Healthcare Purchasing News November Issue Features Solos Endoscopy's MammoView Breast Endoscopy System

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company's Breast Endoscopy System, the MammoView(TM), was featured in the "Product Spotlights" section of the November 2009 issue of Healthcare Purchasing News Magazine. The article focused on the functionality and its ability to perform a variety of procedures with minimal or no discomfort.

The MammoView(TM) instrument line is designed specifically for breast endoscopy. "The MammoView(TM) system produces clear and precise video images allowing for direct observation of extremely confined sites such as the lining of the mammary ducts. (Nearly all breast cancers originate in the epithelial lining of the mammary ducts.) The system allows physicians to perform a variety of intraductal procedures with minimal or no discomfort for patients," as stated in the Healthcare Purchasing News Magazine. Images can be captured in a variety of popular formats allowing consultation and comparison by the physician.

"Solos Endoscopy is pleased to have its MammoView(TM)'s instrument line displayed under the "Product Spotlight" section in one of the surgical industries top magazines. The article will increase the exposure of our entire Solos Endoscopy instrument line to potential customers and partners," stated Bob Segersten, President of Solos Endoscopy, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.